Akebia Therapeutics Stock Forecast

Akebia Therapeutics stock downgraded to Sell Candidate
(Updated on Apr 22, 2024)

AKBA Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Akebia Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.39 and $1.62. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days.

Support, Risk & Stop-loss for Akebia Therapeutics stock

Akebia Therapeutics finds support from accumulated volume at $1.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0600 between high and low, or 4.48%. For the last week, the stock has had daily average volatility of 6.02%.

Akebia Therapeutics is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AKBA) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Akebia Therapeutics to open at $1.37, and during the day (based on 14 day Average True Range), to move between $1.22 and $1.50, which gives a possible trading interval of +/-$0.140 (+/-10.29%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 20.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.35 (0.74%) than the resistance at $1.39 (2.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Akebia Therapeutics stock A Buy?

Akebia Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.119 Sell Candidate Downgraded

Predicted Opening Price for Akebia Therapeutics of Tuesday, April 23, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.